Gemini Space Station Inc vs Tilray Brands Inc — how do they compare? Gemini Space Station Inc trades at $4.29 (market cap $579.55M), while Tilray Brands Inc trades at $3.53 (market cap $530.54M). The key difference: Gemini Space Station Inc and Tilray Brands Inc are close in size by market cap, and Tilray Brands Inc is more actively traded (9,099,075 versus 1,882,406). Which is the better fit depends on your goals — on Pluang, investors hold Gemini Space Station Inc for 14 Days and Tilray Brands Inc for 31 Days on average.
| GEMI | TLRY | |
|---|---|---|
Market Cap | $579.55M | $530.54M |
Volume | 1,882,406 | 9,099,075 |
Sector | Financials | Health |
52-Week High | $25.41 | $21.00 |
52-Week Low | $3.54 | $3.57 |
Typical Hold Time | 14 Days | 31 Days |
Enterprise Value | $558.57M | $684.46M |
Signals from Pluang's Aura AI — not financial advice
Gemini Space Station (GEMI) trades at $4.49, down 3.85% amid bearish technical signals despite recent 31% surge. The company shows concerning fundamentals with negative gross profit margin of -70.25% and net income margin of -250.13% for 2025. Revenue grew 37% YoY in Q2 2026 to $207M, but losses persist with $517M net loss. Analyst consensus is mixed with 33% buy ratings and $5.33 price target, while technical indicators show oversold conditions with RSI at 16.87.
GEMI presents high-risk speculation with significant operational challenges despite revenue growth. The stock's viability depends on reversing deep losses and achieving profitability. Near-term catalysts include SEC's tokenized stock trading pathway, but class action lawsuits and persistent cash burn pose substantial downside risk. Current valuation at 2.75 P/S appears stretched given negative margins.
TLRY trades at $3.715, down 1.72% on the day and near its 52-week low, reflecting persistent bearish technical momentum. The company reported revenue of $821.31M in 2025 but a substantial net loss of -$2.19B, with negative cash flow from operations. Recent quarters show consistent earnings misses versus expectations, though analyst consensus suggests a high price target of $65.01 amid mixed sentiment.
The outlook remains challenged by profitability issues and high debt, but potential catalysts include U.S. cannabis regulatory changes. Investment opportunities hinge on speculative regulatory shifts, while risks include ongoing losses, competitive pressures, and reliance on financing activities to sustain operations.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →